Clinical trial

Dose Ranging Study of Albiglutide in Japanese Subjects

NCT01098461

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE2

Study timeline

Study start (unknown)2010-04-01Date precision: month

Registry last updated2017-01-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

albiglutideBIOLOGICAL

placeboBIOLOGICAL

Sponsors & collaborators

GlaxoSmithKlinelead sponsor

Mapped research locations

FukuokaJapan4 TokyoJapan3 HiroshimaJapan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01098461 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.